Skip to main content

Advertisement

Table 6 Sensitivity analysis of Multiple logistic regression analysis for the prediction of MACCE in ACS patients

From: Glycemic variability determined with a continuous glucose monitoring system can predict prognosis after acute coronary syndrome

Variables Multivariate (Model 1) Multivariate (Model 2) Multivariate (Model 3)
OR 95% CI p-value OR 95% CI p-value OR 95% CI p-value
Patients with DM
 Hypertension 0.435 0.157–1.145 0.092    0.438 0.105–6.510 0.105
 Cre on admission, per 1 mg/dl 1.141 0.407–4.202 0.829    1.208 0.401–4.762 0.768
 BNP during stable phase, per 1 pg/ml 1.002 0.999–1.005 0.053    1.002 0.999–1.005 0.072
 HDLC, per 1 mg/dl 0.962 0.909–1.011 0.134    0.966 0.912–1.017 1.035
 Glucose on admission > 180 mg/dl    2.415 0.861–7.232 0.094 2.038 0.660–6.666 0.217
 HbA1c, per 1%    1.154 0.842–1.575 0.364 1.091 0.753–1.562 0.637
 High MAGE    2.780 1.017–8.956 0.046 3.238 1.041–12.38 0.042
Patients with IGT
 Multivessel disease 4.586 2.028–10.843 < 0.001    4.036 1.747–9.694 0.001
 hs-CRP during stable phase > 0.1355 mg/dl 3.766 1.641–9.226 0.002    3.857 1.664–9.576 0.001
 High MAGE    2.528 1.145–5.581 0.024 2.080 0.861–4.957 0.102
  1. Patients with DM: Model 1 hypertension, Cre on admission, BNP during stable phase and HDLC, Model 2 glucose on admission > 180 mg/dl, HbA1c high MAGE, Model 3 all variables included in Model 1 and 2; Patients with IGT: Model 1 multivessel disease and hs-CRP during stable phase > 0.1355 mg/dl, Model 2 included only High MAGE, Model 3 all variables included in Model 1 and 2. Other abbreviations as in Tables 1, 2, 3, 4